187 related articles for article (PubMed ID: 20473873)
1. The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase.
Chang DY; Yoo SW; Hong Y; Kim S; Kim SJ; Yoon SH; Cho KG; Paek SH; Lee YD; Kim SS; Suh-Kim H
Int J Cancer; 2010 Oct; 127(8):1975-83. PubMed ID: 20473873
[TBL] [Abstract][Full Text] [Related]
2. Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase/5-fluorocytosine in tumor-bearing mice.
NguyenThai QA; Sharma N; Luong do H; Sodhi SS; Kim JH; Kim N; Oh SJ; Jeong DK
J Gene Med; 2015; 17(3-5):87-99. PubMed ID: 25808408
[TBL] [Abstract][Full Text] [Related]
3. The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model.
Fei S; Qi X; Kedong S; Guangchun J; Jian L; Wei Q
J Cancer Res Clin Oncol; 2012 Feb; 138(2):347-57. PubMed ID: 22139383
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy.
Barresi V; Belluardo N; Sipione S; Mudò G; Cattaneo E; Condorelli DF
Cancer Gene Ther; 2003 May; 10(5):396-402. PubMed ID: 12719709
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma.
Kosaka H; Ichikawa T; Kurozumi K; Kambara H; Inoue S; Maruo T; Nakamura K; Hamada H; Date I
Cancer Gene Ther; 2012 Aug; 19(8):572-8. PubMed ID: 22744211
[TBL] [Abstract][Full Text] [Related]
6. Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.
Chung T; Na J; Kim YI; Chang DY; Kim YI; Kim H; Moon HE; Kang KW; Lee DS; Chung JK; Kim SS; Suh-Kim H; Paek SH; Youn H
Theranostics; 2016; 6(10):1477-90. PubMed ID: 27446484
[TBL] [Abstract][Full Text] [Related]
7. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
8. Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.
Kang W; Seol HJ; Seong DH; Kim J; Kim Y; Kim SU; Nam DH; Joo KM
Oncol Rep; 2013 Sep; 30(3):1101-6. PubMed ID: 23828015
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
[TBL] [Abstract][Full Text] [Related]
10. Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma.
Altanerova V; Cihova M; Babic M; Rychly B; Ondicova K; Mravec B; Altaner C
Int J Cancer; 2012 May; 130(10):2455-63. PubMed ID: 21732344
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and the bystander effect in CD::UPRT/5-FC bi-gene therapy of glioma.
Shi DZ; Hu WX; Li LX; Chen G; Wei D; Gu PY
Chin Med J (Engl); 2009 Jun; 122(11):1267-72. PubMed ID: 19567135
[TBL] [Abstract][Full Text] [Related]
12. Antitumor efficiency of the cytosine deaminase/5-fluorocytosine suicide gene therapy system on malignant gliomas: an in vivo study.
Lv SQ; Zhang KB; Zhang EE; Gao FY; Yin CL; Huang CJ; He JQ; Yang H
Med Sci Monit; 2009 Jan; 15(1):BR13-20. PubMed ID: 19114960
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
[TBL] [Abstract][Full Text] [Related]
14. Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
Kazlauskas A; Darinskas A; Meškys R; Tamašauskas A; Urbonavičius J
BMC Cancer; 2019 Mar; 19(1):197. PubMed ID: 30832616
[TBL] [Abstract][Full Text] [Related]
15. Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario.
Altaner C; Altanerova V; Cihova M; Ondicova K; Rychly B; Baciak L; Mravec B
Int J Cancer; 2014 Mar; 134(6):1458-65. PubMed ID: 24038033
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
Krassikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
J Gene Med; 2016 Sep; 18(9):220-33. PubMed ID: 27461566
[TBL] [Abstract][Full Text] [Related]
17. [Experimental treatment of brain tumor cells using CD suicide gene].
Xu LF; Ge K; Zheng ZC; Sun LY; Liu XY
Shi Yan Sheng Wu Xue Bao; 1996 Dec; 29(4):385-93. PubMed ID: 9772683
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
[TBL] [Abstract][Full Text] [Related]
19. Additional effects of engineered stem cells expressing a therapeutic gene and interferon-β in a xenograft mouse model of endometrial cancer.
Yi BR; Kim SU; Choi KC
Int J Oncol; 2015 Jul; 47(1):171-8. PubMed ID: 25963746
[TBL] [Abstract][Full Text] [Related]
20. A preliminary study on the construction of double suicide gene delivery vectors by mesenchymal stem cells and the in vitro inhibitory effects on SKOV3 cells.
Jiang J; Wei D; Sun L; Wang Y; Wu X; Li Y; Fang Z; Shang H; Wei Z
Oncol Rep; 2014 Feb; 31(2):781-7. PubMed ID: 24317390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
